News for Pfizer Limited (PFIZER.BO)

Nifty weekly performance: Indian markets ended the week on a cautious note, with the Nifty slipping 0.7% amid profit booking and global uncertainty. While easing inflation and lower interest rates may support sentiment, investors remain watchful of the July 9 U.S. tariff deadline. FIIs turned cautious, though DIIs lent stability. Trade-sensitive sectors like IT and auto are expected to stay in focus.

Vadodara-based Sudeep Pharma has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO).

Indian markets fell sharply on Tuesday, with Sensex down 873 points and Nifty losing 261 points, amid weak global cues, profit booking, and cautious investor sentiment driven by US fiscal uncertainty and India-US trade concerns.

In the Nifty 50 index, 7 stocks ended in the green, while 43 stocks closed in the red in today's trade.

Markets fell over 1% amid global weakness and profit booking. SRM, Pfizer, and Zydus gained on earnings; Protean and Eternal declined on project loss and foreign ownership concerns, respectively.

Benchmark indices traded lower in the mid-day trading session on Tuesday amid mixed global cues. Sensex depreciated 512.86 pts or 0.62 per cent to 81,546.56 as at 12.56 pm, and Nifty 50 declined 143.10 pts or 0.57 per cent to 24,802.35.

Q4 Results 20th May, 2025 updates: Find all the latest Q4 results 2025 updates for Hindalco Industries, Torrent Pharmaceuticals, Gland Pharma, Solar Industries India, Dixon Technologies, Whirlpool of India, Zydus Lifesciences, JK Tyre & Industries Ltd, Max Healthcare Institute, Khadim India Ltd, Gujarat State Fertilizers & Chemicals Ltd, Bansal Wire Industries Ltd, United Spirits, Fortis Healthcare, Aster DM Healthcare Ltd, Godawari Power & Ispat, Gabriel India, Religare Enterprises, Laxmi Organic Industries, Pearl Global Industries, Electronics Mart India, 63 Moons Technologies, Kirloskar Industries, Arvind SmartSpaces, Automotive Axles, Wheels India, Themis Medicare, Dhunseri Investments, OnMobile Global, Azad India Mobility, Black Rose Industries, Kaycee Industries, BAMPSL Securities,Music Broadcast, Talbros Engineering, Welspun Investments and Commercials, Raj Television Network, Jasch Gauging Technologies, Agarwal Toughened Glass India, Starlineps Enterprises, Coromandel Engineering Company, Standard Industries, Touchwood Entertainment Ltd, Dev Labtech Ventures and few more companies to announce their Q4 results today. Power Grid Corporation of India, Bharat Electronics, DLF, Honda India Power Products, PI Industries, NLC India, Karur Vysya Bank, Petronet LNG, ACME Solar Holdings, Gujarat Gas, Zydus wellness and more announced Q4 results yesterday, May 19, 2025.

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 250 points on Tuesday. The Dow traded up 0.70% to 40,507.41 while the N...

Large Indian drug manufacturers experienced relief as President Trump's administration decided against imposing expected reciprocal tariffs on pharmaceuticals, which could have significantly impacted their earnings. Analysts deem future tariffs unlikely due to potential drug shortages and the influence of major pharma companies investing in the US.

Benchmark BSE Sensex and Nifty declined amidst selling in key stocks like HDFC Bank and Reliance Industries. RIL fell 2%, Polycab gained 3.4%, and Pfizer India dropped 9%. Analysts suggest monitoring Polycab around Rs 4,500, RIL requiring a move above Rs 1,200 to signal recovery, and Angel One demonstrating persistent selling pressure with a support around Rs 1,750.

Benchmark BSE Sensex rebounded 147 points, breaking its five-day decline with gains in financial and FMCG shares. Key stocks: M&M rose by 2%, Federal Bank fell by 1.7%, and Pfizer India decreased by 1.2%. Analysts recommend buying M&M and Federal Bank at dips due to their long-term prospects, while Pfizer India offers promising upside.

Top Nifty 50 gainers: Dr Reddy’s, Mahindra & Mahindra, Eicher Motors, Nestle India, Tata Consumer; IT stocks lagged.

Pfizer shares surged 8.6% to Rs 4,448.35 after announcing a marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacitane. The five-year deal aims to enhance distribution and in-clinic presence. Despite the jump, Pfizer's stock has declined 18.29% YTD.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.17% to 44,499.60 while...

Indian frontline indices broke their two-sessions losing streak on Tuesday after assurances poured-in from various quarters including the government that the Human Metapneumovirus (HMPV) was not lethal and unlike the Covid-19 virus.Banks and energy stocks helped the markets sail through. While the S&P BSE Sensex settled at 78,199.11, up by 234.12 points or 0.30%, the broader Nifty closed at 23,707.90, higher by 91.85 points or 0.39%.Commenting on the day's action, Jatin Gedia, Technical Research Analyst at Mirae Asset Sharekhan said that he sees Nifty consolidating within the range of the previous trading session on the daily charts. It is making the extremes of the penultimate candle, crucial levels to watch out for in the short term i.e. 24,100 – 23,550.

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow traded down 0.26% to 42,461.52 wh...

U.S. stocks traded slightly lower midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.05% to 42,554.24...

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 0.2% on Tuesday. Following the market opening Tuesday, the Dow traded up 0.19% ...

Indian markets declined on Monday, with selling pressure in banks and auto stocks. Subdued trading volumes and FII outflows weighed on sentiment. A strengthening dollar and high valuations also impacted the market. IT and pharma sectors outperformed.